IBDEI0YW ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15570,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,15570,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,15570,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,15571,0)
 ;;=F17.200^^88^864^50
 ;;^UTILITY(U,$J,358.3,15571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15571,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,15571,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,15571,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,15572,0)
 ;;=G43.909^^88^864^48
 ;;^UTILITY(U,$J,358.3,15572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15572,1,3,0)
 ;;=3^Migraine,Unspec
 ;;^UTILITY(U,$J,358.3,15572,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,15572,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,15573,0)
 ;;=H91.93^^88^864^34
 ;;^UTILITY(U,$J,358.3,15573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15573,1,3,0)
 ;;=3^Hearing Loss,Bilateral
 ;;^UTILITY(U,$J,358.3,15573,1,4,0)
 ;;=4^H91.93
 ;;^UTILITY(U,$J,358.3,15573,2)
 ;;=^5006944
 ;;^UTILITY(U,$J,358.3,15574,0)
 ;;=I10.^^88^864^41
 ;;^UTILITY(U,$J,358.3,15574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15574,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,15574,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,15574,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,15575,0)
 ;;=I50.9^^88^864^17
 ;;^UTILITY(U,$J,358.3,15575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15575,1,3,0)
 ;;=3^Congestive Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,15575,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,15575,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,15576,0)
 ;;=I67.89^^88^864^16
 ;;^UTILITY(U,$J,358.3,15576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15576,1,3,0)
 ;;=3^Cerebrovascular Disease,Oth
 ;;^UTILITY(U,$J,358.3,15576,1,4,0)
 ;;=4^I67.89
 ;;^UTILITY(U,$J,358.3,15576,2)
 ;;=^5007388
 ;;^UTILITY(U,$J,358.3,15577,0)
 ;;=J45.909^^88^864^4
 ;;^UTILITY(U,$J,358.3,15577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15577,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,15577,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,15577,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,15578,0)
 ;;=J44.9^^88^864^14
 ;;^UTILITY(U,$J,358.3,15578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15578,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,15578,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,15578,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,15579,0)
 ;;=K21.9^^88^864^29
 ;;^UTILITY(U,$J,358.3,15579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15579,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,15579,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,15579,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,15580,0)
 ;;=N40.1^^88^864^27
 ;;^UTILITY(U,$J,358.3,15580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15580,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,15580,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,15580,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,15581,0)
 ;;=L03.818^^88^864^15
 ;;^UTILITY(U,$J,358.3,15581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15581,1,3,0)
 ;;=3^Cellulitis,Oth Sites
 ;;^UTILITY(U,$J,358.3,15581,1,4,0)
 ;;=4^L03.818
 ;;^UTILITY(U,$J,358.3,15581,2)
 ;;=^5009064
 ;;^UTILITY(U,$J,358.3,15582,0)
 ;;=G47.33^^88^864^75
 ;;^UTILITY(U,$J,358.3,15582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15582,1,3,0)
 ;;=3^Sleep Apnea,Obstructive
 ;;^UTILITY(U,$J,358.3,15582,1,4,0)
 ;;=4^G47.33
 ;;^UTILITY(U,$J,358.3,15582,2)
 ;;=^332763
